| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 75.2106 | 71 |
| GSM780708 | Untreated after 4 days (C2_1) | 78.6759 | 71 |
| GSM780709 | Untreated after 4 days (C3_1) | 69.4921 | 69 |
| GSM780719 | Untreated after 4 days (C1_2) | 82.2314 | 72 |
| GSM780720 | Untreated after 4 days (C2_2) | 79.0752 | 71 |
| GSM780721 | Untreated after 4 days (C3_2) | 82.3261 | 72 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 75.831 | 71 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 87.4067 | 73 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 75.3072 | 71 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 71.2494 | 69 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 80.411 | 72 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 91.7243 | 74 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 83.8553 | 72 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 73.2399 | 70 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 83.968 | 73 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 87.7818 | 73 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 76.1194 | 71 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 82.2314 | 72 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 89.8537 | 74 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 91.4882 | 74 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 84.4383 | 73 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 73.5449 | 70 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 78.1538 | 71 |